Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
By Hirenkumar K. Makadia, Steven J. Siegel. Polymers, 2011
4,247 citations recorded by the source corpus.
In past two decades poly lactic-co-glycolic acid (PLGA) has been among the most attractive polymeric candidates used to fabricate devices for drug delivery and tissue engineering applications. PLGA is biocompatible and biodegradable, exhibits a wide range of erosion times, has tunable mechanical properties and most importantly, is a FDA approved polymer. In particular, PLGA has been extensively studied for the development of devices for controlled delivery of small molecule drugs, proteins and other macromolecules in commercial use and in research. This manuscript describes the various fabrication techniques for these devices and the factors affecting their degradation and drug release.
Subfields: Biomaterials, Pharmaceutical Science
View Paper: https://www.semanticscholar.org/paper/3649c008437b4a4a59c67419af5d7fe7bf3594a7
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
In Pharmaceutical Science
Citations in the corpus
- A breathable, biodegradable, antibacterial, and self-powered electronic skin based on all-nanofiber triboelectric nanogenerators (2020, neutral): “S28) ( 40 , 44 ).”
- Review of Multifarious Applications of Poly (Lactic Acid) (2016, background): “For a very long-term release requirement (more than 6 months), a semicrystalline polymer with high degree crystallinity such as PLA ought to be considered([130]).”
- An Overview of Poly(lactic-co-glycolic) Acid (PLGA)-Based Biomaterials for Bone Tissue Engineering (2014, background): “Unlike pure polylactic and polyglycolic acid show poor solubilities, PLGA can be dissolved by a wide range of common solvents, including chlorinated solvents, tetrahydrofuran, acetone or ethyl acetate [28] and it can be processed into any shape and size, and can encapsulate biomolecules of any size.”
- Vaccine adjuvants: mechanisms and platforms (2023, background): “Therefore, we believe that a PLGA-based vaccine delivery system will be approved for human use in the near future.(285,286)”
- Therapeutic Strategies for Enhancing Angiogenesis in Wound Healing (2018, background): “During degradation, poly(lactic-co-glycolic acid) (PLGA) scaffolds hydrolyze into lactic and glycolic acids [124].”